{"doc_desc":{"title":"\u00c9tude transversale \u00e9valuant la pr\u00e9valence des co-addictions chez des sujets b\u00e9n\u00e9ficiant d\u2019un traitement de substitution aux opiac\u00e9s : d\u00e9termination du profil clinique et pharmacologique","idno":"FRESH-PEF73282-fr","producers":[{"name":"Marie GRALL-BRONNEC","affiliation":"CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES"}]},"study_desc":{"title_statement":{"idno":"FRESH-PEF73282-fr","IDno":{"metadata_no":[{"agency":"PEF","code":"73282"},{"agency":"FReSH","code":"FRESH-PEF73282"}]},"title":"\u00c9tude transversale \u00e9valuant la pr\u00e9valence des co-addictions chez des sujets b\u00e9n\u00e9ficiant d\u2019un traitement de substitution aux opiac\u00e9s : d\u00e9termination du profil clinique et pharmacologique","alternate_title":"OPAL"},"study_authorization":{"agency":[{"name":"CNIL"},{"name":"CESREES"}]},"authoring_entity":[{"name":"Marie;GRALL-BRONNEC","firstname":"Marie","lastname":"GRALL-BRONNEC","type":"investigator","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/05c1qsg97","role":"organisation id"},{"title":"SIREN","uri":"264400136","role":"organisation id"}],"email":"marie.bronnec@chu-nantes.fr","affiliationName":"CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES","PILabo":"Chu de Nantes \/ Addiction department of the CHU de Nantes \/ UIC 18 Clinical Investigation Unit: Behavioural addictions and complex mood disorders \/ EA 4275 SPHERE","isContact":true}],"oth_id":[{"name":"Etude multicentrique en collaboration avec le CHU de Brest, le CHU d'Angers, le CH de Morlaix, le CH G. R\u00e9gnier de Rennes, Les CSAPA \"Le Triangle\" (Nantes), \"La m\u00e9tairie\" (La Roche S\/ Yon) et \"La rose des vents\" (St Nazaire), le SMPR de Nantes et le R\u00e9seau Toxicomanie de la R\u00e9gion Nantaise (RTRN)","type":"collaboration"}],"production_statement":{"prod_place":"Portail Epid\u00e9miologie France (PEF)","producers":[{"name":"CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/05c1qsg97","role":"sponsor id"},{"title":"SIREN","uri":"264400136","role":"sponsor id"}],"role":"sponsor"}],"funding_agencies":[{"name":""}]},"distribution_statement":{"contact":[{"name":"Marie;GRALL-BRONNEC","lastname":"GRALL-BRONNEC","firstname":"Marie","type":"contact","email":"marie.bronnec@chu-nantes.fr","affiliationName":"CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES","contactPointLabo":"","extlink":[{"uri":"https:\/\/ror.org\/05c1qsg97","role":"organisation id","title":"ROR"},{"uri":"264400136","role":"organisation id","title":"SIREN"}]}]},"study_info":{"keywords":[{"keyword":"D\u00e9pendance aux opiac\u00e9s"},{"keyword":"traitements de substitution aux opiac\u00e9s"},{"keyword":"substance psychoactive"},{"keyword":"pharmacocin\u00e9tique"},{"keyword":"pharmacog\u00e9n\u00e9tique"},{"keyword":"polymorphisme"},{"keyword":"cytochrome P450 2D6."},{"keyword":"addictions"},{"keyword":"jeu pathologique"}],"topics":[{"topic":"Psychiatrie","vocab":"health theme","extLink":[{"title":"ESV","uri":"http:\/\/data.europa.eu\/8mn\/euroscivoc\/3de50dee-da1c-4791-a386-56bca24a5fed"},{"title":"MeSH","uri":"http:\/\/id.nlm.nih.gov\/mesh\/D011570"}]},{"topic":"Addictologie","vocab":"health theme","extLink":[{"title":"ESV","uri":"http:\/\/data.europa.eu\/8mn\/euroscivoc\/42d645e0-f58d-40ed-9917-5b227ff41a92"},{"title":"MeSH","uri":"http:\/\/id.nlm.nih.gov\/mesh\/D000073316"}]},{"topic":"Troubles mentaux, comportementaux ou neurod\u00e9veloppementaux","vocab":"cim-11","extLink":[{"uri":"http:\/\/id.who.int\/icd\/entity\/334423054","title":"CIM-11"}]},{"topic":"D\u00e9terminants comportementaux : Addictions","vocab":"health determinant"},{"topic":"D\u00e9terminants biologiques : Pr\u00e9dispositions g\u00e9n\u00e9tiques","vocab":"health determinant"},{"topic":"D\u00e9terminants comportementaux","vocab":"health determinant"},{"topic":"D\u00e9terminants biologiques","vocab":"health determinant"}],"purpose":"\u00e9valuer la pr\u00e9valence actuelle des comorbidit\u00e9s addictives chez des sujets d\u00e9pendants aux opiac\u00e9s, b\u00e9n\u00e9ficiant d\u2019un traitement de substitution aux opiac\u00e9s (TSO) depuis au moins 6 mois.","abstract":"","coll_dates":[{"start":"2013-01-01","end":"2016-01-01"}],"nation":[{"name":"France","abbreviation":"fr","extLink":{"vocab":"ISO","vocabURI":"fr"}}],"geog_coverage":"","analysis_unit":"Individus","universe":"{\n    \"level_sex_clusion_I\": [\n        {\n            \"value\": \"Masculin\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D008297\"\n            }\n        },\n        {\n            \"value\": \"F\u00e9minin\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D005260\"\n            }\n        }\n    ],\n    \"level_age_clusion_I\": [\n        {\n            \"value\": \"Adulte (19 \u00e0 24 ans)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D055815\"\n            }\n        },\n        {\n            \"value\": \"Adulte (25 \u00e0 44 ans)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D000328\"\n            }\n        },\n        {\n            \"value\": \"Adulte (45 \u00e0 64 ans)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D008875\"\n            }\n        },\n        {\n            \"value\": \"Personne \u00e2g\u00e9e (65 \u00e0 79 ans)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D000368\"\n            }\n        }\n    ],\n    \"level_type_clusion_I\": \"Patients\",\n    \"level_type_clusion_other\": \"\",\n    \"clusion_I\": \"Majeur Traitement par m\u00e9thadone ou bupr\u00e9norhine (+\\\/- naloxone) ou morphine \u00e0 vis\u00e9e substitutive, prescrit en raison d\u2019une d\u00e9pendance aux opiac\u00e9s TSO instaur\u00e9 depuis au moins 6 mois Incarc\u00e9ration datant de moins d\u2019un mois en cas de suivi au SMPR Bonne compr\u00e9hension du fran\u00e7ais, sachant lire et \u00e9crire.\",\n    \"clusion_E\": \"\"\n}","data_kind":"['Donn\u00e9es cliniques','Donn\u00e9es rapport\u00e9es par le participant de l&#x27;\u00e9tude']","quality_statement":{"standards":[{"name":"","committee":"","governance":""}],"other_quality_statement":"['v\u00e9rification des donn\u00e9es par un TEC et de la coh\u00e9rence des donn\u00e9es par la cellule data lors de la saisie dans la base de donn\u00e9es informatique']"}},"study_development":{"development_activity":[{"activity_type":"primary evaluation","activity_description":"Ev\u00e9nements de sant\u00e9\/morbidit\u00e9"}]},"method":{"data_collection":{"time_method":"Etude transversale non r\u00e9p\u00e9t\u00e9e","frequency":"","sampling_procedure":"['{\"concept\":{\"vocabURI\":\"Other\",\"vocab\":\"CESSDA\"},\"value\":\"Autre\"}']","sample_frame":{"frame_unit":{"unit_type":"['Via des structures (services ou \u00e9tablissements de sant\u00e9, \u00e9coles, entreprises\u2026)']"}},"coll_mode":["{\"concept\":{\"vocabURI\":\"Interview\",\"vocab\":\"CESSDA\"},\"value\":\"Entretien avec le participant (dont clinique)\"}"],"research_instrument":"Acc\u00e8s restreint sur projet sp\u00e9cifique","sources":[],"target_sample_size":"< 500 individus","response_rate":"263"},"method_notes":"Etude observationnelle","study_class":"\u00c9tude compl\u00e9t\u00e9e","notes":[{"subject":"research type","values":["Etude observationnelle"]}]},"data_access":{"dataset_availability":{"access_place":"","complete":"","status":"{\"value\":\"Acc\u00e8s r\u00e9serv\u00e9\",\"extLink\":[{\"title\":\"COAR\",\"uri\":\"http:\/\/purl.org\/coar\/access_right\/c_16ec\"}]}"},"dataset_use":{"restrictions":"","conditions":"Contacter le responsable scientifique","conf_dec":[{"txt":""}],"spec_perm":[{"txt":"","required":""}],"contact":[{"name":""}],"deposit_req":"","cit_req":""},"notes":""}},"additional":{"IsImport":true,"versionLang":"fr","originLang":"fr","autoTranslation":false,"status":"imported","creationDate":"20-11-2015","lastUpdatedAuto":null,"lastUpdatedManual":"17-02-2020","isContributorPI":false,"contributorName":"","contributorAffiliation":"","addTeamMember":"","obtainedAuthorization":{"otherAuthorizingAgency":["",""]},"relatedDocument":[],"regulatoryRequirements":{"conformityDeclaration":""},"fundingAgent":{"fundingAgentType":[],"otherFundingAgentType":[]},"sponsor":{"sponsorType":["Public (France)"],"otherSponsorType":[""]},"governance":{"committee":false},"collaborations":{"networkConsortium":true},"theme":{"complementaryInformation":"","RareDiseases":""},"activeFollowUp":{"isActiveFollowUp":false,"followUpModeOther":""},"interventionalStudy":{"researchPurpose":[],"trialPhase":[],"interventionalStudyModel":"","isClinicalTrial":"","otherResearchPurpose":""},"isInclusionGroups":"","allocation":{"allocationMode":"","allocationUnit":""},"masking":{"maskingType":"","blindedMaskingDetails":[]},"arms":[],"intervention":[],"inclusionGroups":[],"collectionProcess":{"collectionModeDetails":"recueil des donn\u00e9es en consultation par le m\u00e9decin et\/ou l'infirmier","collectionModeOther":""},"dataCollection":{"inclusionStrategyOther":"","samplingModeOther":"","recruitmentSourceOther":"","otherDocumentation":""},"dataCollectionIntegration":{"isDataIntegration":false},"geographicalCoverage":{"geoDetail":"Nantes, Brest, Morlaix, Angers, Rennes, St Nazaire"},"dataTypes":{"clinicalDataDetails":"","biologicalDataDetails":"","isDataInBiobank":true,"biobankContent":[],"biobankContentOther":"","dataTypeOther":""},"variableDictionnary":{"variableDictionnaryAvailable":"","variableDictionnaryLink":""},"dataQuality":{"otherDocumentation":""},"mockSample":{"mockSampleAvailable":"","mockSampleLocation":""},"thirdPartySource":{"otherSourceType":[]},"isHealthTheme":true,"fileDscr":{"fileTxt":{"fileCitation":{"titlStmt":{"IDno":[]}}}}},"schematype":"survey"}